Objective-To investigate the effect of intracardiac repair on the abnormal biosynthesis of prostacyclin (PGI,) and thromboxane A, (TXA,) in children with congenital heart disease and increased pulmonary blood flow. Design-A prospective study with immunoaffinity chromatography and gas chromatography-mass spectrometry to measure the urinary excretion products of PGI, (2,3-dinor-6-oxo-prostaglandin (PG) F,8 (2,3-dinor-6-oxo-PGF,.)) and TXA, (2,3-dinor-TXB,) before operation, in the first 12-24 h after operation, and at discharge from hospital. Setting-A supraregional referral centre for patients with congenital heart disease. Patients-15 patients aged 2 to 60 months (median 7 months) with a left to right shunt who underwent intracardiac repair. Results-The preoperative 2,3-dinor-TXB, excretion rate was greater than that found previously in a control group of 16 healthy children with a median (range) age of 24 (6-36) months (1159(201) v 592(122) nglg creatinine in controls, P = 0.006). The excretion rate rose after operation to 9600(3832) nglg creatinine (P = 0'01) and decreased before discharge to 1071(191) ng/g creatinine (NS), but remained greater than that of the control group (P = 0-014). Before operation 2,3-dinor-6-oxo-PGF,. excretion rates were similar to those of the healthy children (482(68) v 589(95) ng/g creatinine in controls) but increased after operation to 19 668(11 162) nglcreatinine (P = 0-002) and fell at discharge to 1621(245) nglg creatinine although this was higher than both preoperative and control rates (P = 0-005 and P = 0-0002 respectively). The preoperative ratio of 2,3-dinor-TXB, to 2,3-dinor-6-oxo-PGF1. excretion was greater than that of the control group (3.2(0.8) v 1.3(0-22) in controls, (P = 0.005)), decreased significantly after operation to 0.9(0.13) (P = 0-016), and changed little, to 0-7(0-12), before discharge. The last two ratios were similar to those in normal children and significantly lower than those before operation (P = 0.004).
TXA, (2,3-dinor-TXB,) before operation, in the first 12-24 h after operation, and at discharge from hospital. Setting-A supraregional referral centre for patients with congenital heart disease. Patients-15 patients aged 2 to 60 months (median 7 months) with a left to right shunt who underwent intracardiac repair. Results-The preoperative 2,3-dinor-TXB, excretion rate was greater than that found previously in a control group of 16 healthy children with a median (range) age of 24 months (1159(201) v 592(122) nglg creatinine in controls, P = 0.006). The excretion rate rose after operation to 9600(3832) nglg creatinine (P = 0'01) and decreased before discharge to 1071(191) ng/g creatinine (NS), but remained greater than that of the control group (P = 0-014). Before operation 2, 3- dinor-6-oxo-PGF,. excretion rates were similar to those of the healthy children (482(68) v 589(95) ng/g creatinine in controls) but increased after operation to 19 668 (11 162) nglcreatinine (P = 0-002) and fell at discharge to 1621(245) nglg creatinine although this was higher than both preoperative and control rates (P = 0-005 and P = 0-0002 respectively). The preoperative ratio of 2,3-dinor-TXB, to 2,3-dinor-6-oxo-PGF1. excretion was greater than that of the control group (3.2(0.8) v 1.3(0-22) in controls, (P = 0.005)), decreased significantly after operation to 0.9(0.13) (P = 0-016), and changed little, to 0-7(0-12), before discharge. The last two ratios were similar to those in normal children and significantly lower than those before operation (P = 0.004).
Conclusion-In children with a left to right shunt the ratio of the excretion rates of the metabolites of TXA, and PGI, was abnormal before operation, which favoured vasoconstriction and platelet aggregation, but had decreased at discharge from hospital. The increase in excretion of PGI, metabolites over TXA, metabolite after intracardiac repair augurs well for pulmonary vascular recovery.
(Br Heart J 1994;72:452-456)
The pulmonary circulation is exposed to a high shear stress from birth in children with congenital heart disease and a left to right shunt. Structural abnormalities are known to be present by 2 months of age but endothelial dysfunction precedes morphological damage. 1-3 Recent studies have shown that the metabolism of several vasoactive mediators is abnormal in children with pulmonary hypertensive congenital heart disease.45 An imbalance in eicosanoid biosynthesis with an excess of thromboxane A2 (TXA2) over prostacyclin (PGI,) may occur,4 as in pulmonary hypertension of other aetiologies. 6 The vasoconstrictor TXA2 is a proaggregatory substance whereas PGI2 acts as a physiological antagonist to TXA2, relaxing vascular smooth muscle and inhibiting platelet aggregation.7-9 Thus before operation, children with pulmonary hypertensive congenital heart disease have an imbalance in favour of vasoconstriction and platelet aggregation.
Cardiopulmonary bypass damages the pulmonary endothelium in all patients and those with pulmonary hypertension are particularly vulnerable.'10-14 Pulmonary hypertension might be mediated by an increase in a vasoconstrictor or decrease in a vasodilator substance. The circulating concentration of the vasoactive substance derived from the endothelium, endothelin, is high in such children,5 but the release of nitric oxide in response to acetylcholine may be impaired. ' The results were expressed as mean (SEM) ng eicosanoid/g urinary creatinine to allow for changes in renal function and urine volume. All data were transformed logarithmically to obtain normally distributed data before analysis. Urinary eicosanoid excretion rates were compared with those found previously in a control group of 16 normal children aged 6-36 (median 24) months with the unpaired Student's t test.4 Differences were considered significant at P < 0 05. For comparison of preoperative, intensive care unit (ICU), and discharge values, only paired urine samples from the same patients were studied. A one way analysis of variance (ANOVA) for repeated measures was used to detect differences in the excretion rates of eicosanoids before operation, on the intensive care unit, and at discharge. When significant differences were found (P < 0-05) the Bonferroni procedure for multiple comparisons was used to test for pairwise differences. These were considered significant at P < 0-017. In the three children who had a complicated postoperative course eicosanoid biosynthesis was considered to be different from the group without postoperative complications if their values fell above or below the upper and lower 95% confidence interval (95% CI) of that group.
Results
The mean preoperative excretion rate of 2,3-dinor-TXB2 was 1159(201) ng/g creatinine, significantly higher than the excretion rate of 592(122) ng/g creatinine in the healthy control group (P = 0 006). Excluding the three children who had a complicated postoperative course, the rate of 2,3-dinor-TXB2 excretion increased from the preoperative rate of 1159(697) to 9600(3832) ng/g creatinine in the intensive care unit (P = 0-014), and was 1071(191) ng/g creatinine immediately before discharge P = 0 035 (NS). Its rate of excretion on discharge from hospital was not significantly different from the preoperative rate, but was significantly greater than in the control group (P = 00 14).
Before operation, the mean urinary excretion rate of 2,3-dinor-6-oxo-PGFi, was 482(68) ng/g creatinine, similar to the control group (589(95) ng/g creatinine). At 12-24 hours after operation, in the intensive care unit, the rate rose to 19 668(11 162) ng/g creatinine (P = 0.002), and before discharge, it had fallen to 1621(245) ng/g creatinine. This value was higher than both the preoperative baseline values (P = 0 005) and the control group (P = 0 0002). The ratio of 2,3-dinor-TXB2: 2,3-dinor-6-oxo-PGF,a excretion before operation was 3-2(0 8), compared with a control ratio of 1-3(0-22) (P = 0 005). At 12-24 hours after operation, the ratio decreased to 0-9(0 13) (P = 0-016). This ratio was similar at the time of discharge (0-7(0-12)) and less than the preoperative value (P = 0 004). The ratio at discharge was not significantly different from the control value.
Concerning the three children who had a complicated postoperative course, in the two who had a residual left to right shunt, the excretion of 2,3-dinor-6-oxo-PGFia at the time of discharge was below the lower 95% CI (440 and 465 compared with upper and lower 95% CIs of 1056 and 2185 ng/g creatinine) for the rest of the patients, although excretion of the 2,3-dinor-TXB2 was similar. The ratios of 2,3-dinor-TXB2: 2,3-dinor-6-oxo-PGFj, at discharge were above the 95% CI of the other patients (2-6 and 3*9 compared with lower and upper 95% CIs of 0-4-1-0). One of these children had a postoperative peak right ventricular pressure of 50 mm Hg and a pulmonary:systemic flow ratio of 2:1. He subsequently underwent a second and successful intracardiac repair. On that occasion the excretion of the 2,3-dinor-6-oxo-PGFia at the time of discharge was greater than that seen in any other child and the ratio was 0 5.
The child who had postoperative pulmonary hypertensive crises had a lower excretion rate of 2,3-dinor-6-oxo-PGFia at 12-24 hours after surgery, during the crises, than any other child in the group. During the time the child was ill in the intensive care unit the eicosanoid metabolite excretion ratio was 4 0, well above the 95% CI (06-1 0) for the postoperative group of patients with an uncomplicated course.
Discussion
Before operation, the 12 hour excretion rate of 2,3-dinor-TXB2 was high whereas that of 2,3-dinor-6-oxo-PGFia was at the lower limit of the control group. This significantly increased the ratio. These findings are consistent with those in our previous study in which we found high 2,3-dinor-TXB, excretion in children with congenital heart disease and a high pulmonary blood flow, compared with the same control group.4 In the present study, after operation excretion of both eicosanoid metabolites was noticeably high for longer than has previously been reported.'617 Other investigators reported an increase in the plasma concentration of 6-oxo-PGF,, and TXB, in children during cardiopulmonary bypass that quickly returned to the preoperative concentration in the recovery room.'6 17 In patients undergoing palliative cardiac surgery without cardiopulmonary bypass the plasma concentration of TXB2 did not change whereas that of 6-oxo-PGF,a increased,'7 possibly attributable to intravascular manipulation. In our study, the pronounced increase in both 2,3-dinor-TXB, and 2,3-dinor-6-oxo-Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt PGF,a immediately after operation may likewise reflect intravascular manipulation. The increase in 2,3-dinor-TXB2 after operation might be regarded as an exaggeration of the preoperative state, as cardiopulmonary bypass is known to activate platelets and damage the pulmonary endothelium, which is already injured in pulmonary hypertensive children before bypass.'2 1127 The circulating concentration of another vasoactive substance, endothelin, also increases immediately after cardiopulmonary bypass although unlike TXA2, the circulating concentration of this mediator is normal before operation. 28 Cardiopulmonary bypass damages all endothelia, and the proportion of TXA2 and endothelin produced by the systemic and pul- It has been suggested that because of the opposing effects of TXA2 and PGI2 on blood vessels and platelets, the ratio of biosynthesis of TXA2 to PGI2 may have greater physiological relevance than changes in the biosynthesis of either eicosanoid alone.820 The ratio is abnormal in several different vascular diseases.6 20 23 32 33 In our study, the ratio of excretion of 2,3-dinor-TXB2: 2,3-dinor-6-oxoPGFia was similar to the control group between 12 and 24 hours after cardiopulmonary bypass on account of the increase in PGI2. One exceptional case had pulmonary hypertensive crises and in this child the eicosanoid metabolite excretion ratio was above the upper 95% CI of the other children. These findings raise the possibility that the unopposed action of TXA2 may contribute to the pathogenesis of pulmonary hypertensive crises, and might help to explain why an infusion of PGI2 is generally more helpful in treating crises than other intravenous vasodilators.34 Thromboxane receptor antagonism prevents pulmonary hypertension and improves right ventricular function after complement induced pulmonary hypertension in dogs and may prove to be a useful adjunct in the treatment of pulmonary hypertension after cardiopulmonary bypass in humans. 35 Other vasoactive mediators, such as endothelin, may contribute to postoperative pulmonary vascular reactivity, and nitric oxide release may be impaired.5 '5 Nitric oxide has been shown to be an effective pulmonary vasodilator after surgery for congenital heart disease in children."5 Nevertheless, in our study the rise in the 2,3-dinor-TXB2: 2,3-dinor-6-oxo-PGF,a excretion ratio during a hypertensive crisis suggests an aetiological role for this vasoconstrictor in pulmonary hypertensive crises.
By the time the patients were discharged from hospital, at a median of 12 days after operation, the excretion rate of 2,3-dinor-TXB2 was still high. Whether this indicates persistent platelet dysfunction after cardiopulmonary bypass or chronic endothelial injury is unknown. The excretion rate of 2,3-dinor-6-oxo-PGF,a in those who had undergone a successful repair was greater than in the control group. The mechanism of this change is not understood, although surgery is known to stimulate PGI2 production. 14 Excretion of 2,3-dinor-6-oxo-PGFia was low, however, after operation in the two patients with a large residual ventricular septal defect. Paradoxically, in vitro an increase in shear stress increases the release of PGI2.'6 Also, for those patients with a low rate of 2,3-dinor-6-oxoPGFia excretion, it was not possible in our study to discriminate between the direct effect of the increased pulmonary blood flow after operation and its probable consequences, left atrial hypertension, and cardiac dysfunction after bypass.
The postoperative increase in excretion of 2,3-dinor-6-oxo-PGF,a after a successful repair meant that when the patients were discharged from hospital the ratio of excretion of the metabolites was similar to that in the control group. A previous study has shown that one year after a successful repair the excretion rates of TXB2 and PGFia are normal, indicating recovery of endothelial function.4 Endothelial dependent relaxation in response to acetylcholine is preserved in young children with an increase in pulmonary blood flow, but is impaired in older patients with fixed pulmonary vascular disease.'5 37 Progressive endothelial dysfunction may be evident as an imbalance in eicosanoid biosynthesis that might contribute to the pathogenesis of pulmonary vascular disease. Although the numbers in our study are small, the return to normal of the ratio soon after intracardiac repair indicates rapid restoration of the balance between vasoconstrictor and dilator mediators and augurs well for the reversibility of the structural abnormalities. 
